Optimizing doses of a first line chemotherapy treatment containing epirubicin, paclitaxel and capecitabine (TEX) in metastatic breast cancer.

被引：0
|
作者：
Einbeigi, Z
Bergström, D
Hatschek, T
Malmberg, M
机构：
[1] Sahlgrens Univ Hosp, S-41345 Gothenburg, Sweden
[2] Roche AB, Stockholm, Sweden
[3] Karolinska Hosp, S-10401 Stockholm, Sweden
[4] Helsingborg Hosp, Helsingborg, Sweden
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2003年 / 82卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
539
引用
收藏
页码：S131 / S131
页数：1
相关论文
共 50 条
  • [1] Paclitaxel, Epirubicin and Capecitabine (TEX) as First-Line Treatment for Metastatic Breast Cancer: a Pilot Phase I/II Feasibility Study
    Einbeigi, Z.
    Bergstrom, D.
    Hatschek, T.
    Malmberg, M.
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2008, 2 : 533 - 538
  • [2] Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial
    T. Hatschek
    L. Carlsson
    Z. Einbeigi
    E. Lidbrink
    B. Linderholm
    B. Lindh
    N. Loman
    M. Malmberg
    S. Rotstein
    M. Söderberg
    M. Sundquist
    T. M. Walz
    M. Hellström
    H. Svensson
    G. Åström
    Y. Brandberg
    J. Carstensen
    M. Fernö
    J. Bergh
    [J]. Breast Cancer Research and Treatment, 2012, 131 : 939 - 947
  • [3] Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial
    Hatschek, T.
    Carlsson, L.
    Einbeigi, Z.
    Lidbrink, E.
    Linderholm, B.
    Lindh, B.
    Loman, N.
    Malmberg, M.
    Rotstein, S.
    Soderberg, M.
    Sundquist, M.
    Walz, T. M.
    Hellstrom, M.
    Svensson, H.
    Astrom, G.
    Brandberg, Y.
    Carstensen, J.
    Ferno, M.
    Bergh, J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (03) : 939 - 947
  • [4] Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first line chemotherapy, in advanced breast cancer.
    Fountzilas, G
    Papadimitriou, C
    Bafaloukos, D
    Skarlos, D
    Kalofonos, HP
    Aravantinos, G
    Papakostas, P
    Kosmidis, P
    Pavlidis, N
    Dimopoulos, MA
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 26 - 26
  • [5] Paclitaxel/mitoxantrone as first line chemotherapy for metastatic breast cancer
    Enrech, S
    Rivero, B
    DeGranda, JI
    Tafalla, JJ
    Cerezuela, P
    Menendez, PC
    Lopez, G
    Claros, F
    Brana, J
    Sancho, JF
    [J]. 10TH MEDITERRANEAN CONGRESS OF CHEMOTHERAPY, 1996, : 485 - 488
  • [6] Individually dose-adjusted treatment with epirubicin and paclitaxel with or without capecitabine as 1st line treatment in metastatic breast cancer. A randomized multicenter trial
    Hatschek, T.
    Einbeigi, Z.
    Walz, T.
    Malmberg, M.
    Loman, N.
    Carlsson, L.
    Soderberg, M.
    Linderholm, B.
    Lindh, B.
    Sundqvist, M.
    [J]. EJC SUPPLEMENTS, 2010, 8 (03): : 195 - 196
  • [7] Optimizing paclitaxel/epirubicin treatment in advanced breast cancer
    Conte, PF
    Gennari, A
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (01) : 34 - 34
  • [8] Epirubicin and vinorelbine versus single agent epirubicin as first line chemotherapy in metastatic breast cancer
    Ejlertsen, B
    Mouridsen, H
    Langkjer, ST
    Andersen, J
    Sjostrom, J
    Kjaer, M
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S66 - S67
  • [9] Phase II study of vinorelbine and capecitabine as first-line treatment for metastatic breast cancer.
    El-Sadda, Wael
    Halim, Inas Ibraheim Abdel
    Aziz, Mohamed Abdel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] WEEKLY EPIRUBICIN AND DOCETAXEL AS FIRST-LINE CHEMOTHERAPY IN METASTATIC BREAST CANCER
    D'Ottavio, A.
    Vaccaro, A.
    Belli, F.
    Nunziata, C.
    Meliffi, L.
    Moscetti, L.
    Barduagni, M.
    Sperduti, I.
    Gamucci, T.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 19 - 19
12345